Literature DB >> 23759730

Putting GWAS to the functional test: NR5A2 and pancreatic cancer risk.

L Charles Murtaugh.   

Abstract

Entities:  

Keywords:  Pancreatic Cancer; Pancreatitis

Mesh：

Substances：

Year:  2013        PMID： 23759730     DOI： 10.1136/gutjnl-2013-305030

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

Review 1.  Nuclear receptors and pathogenesis of pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

2.  Iterative use of nuclear receptor Nr5a2 regulates multiple stages of liver and pancreas development.

Authors:  Sahar Nissim; Olivia Weeks; Jared C Talbot; John W Hedgepeth; Julia Wucherpfennig; Stephanie Schatzman-Bone; Ian Swinburne; Mauricio Cortes; Kristen Alexa; Sean Megason; Trista E North; Sharon L Amacher; Wolfram Goessling
Journal:  Dev Biol       Date:  2016-07-26       Impact factor: 3.582

3.  Genome-wide association studies and epigenome-wide association studies go together in cancer control.

Authors:  Mukesh Verma
Journal:  Future Oncol       Date:  2016-04-15       Impact factor: 3.404

4.  Nuclear receptor NR5A2 negatively regulates cell proliferation and tumor growth in nervous system malignancies.

Authors:  Dimitrios Gkikas; Dimitris Stellas; Alexia Polissidis; Theodora Manolakou; Maroula G Kokotou; George Kokotos; Panagiotis K Politis
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 11.205

5.  Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case-control studies.

Authors:  Qun Chen; Hao Yuan; Guo-Dong Shi; Yang Wu; Dong-Fang Liu; Yu-Ting Lin; Lei Chen; Wan-Li Ge; Kuirong Jiang; Yi Miao
Journal:  Onco Targets Ther       Date:  2018-05-09       Impact factor: 4.147

6.  Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancer.

Authors:  Yang-Yang Zhou; Li-Ping Chen; Yi Zhang; Sun-Kuan Hu; Zhao-Jun Dong; Ming Wu; Qiu-Xiang Chen; Zhi-Zhi Zhuang; Xiao-Jing Du
Journal:  Mol Med       Date:  2019-11-09       Impact factor: 6.354
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.